DEPO-MEDRONE

This brand name is authorized in Ireland, Malta, United Kingdom

Active ingredients

The drug DEPO-MEDRONE contains one active pharmaceutical ingredient (API):

1 Methylprednisolone UNII 43502P7F0P - METHYLPREDNISOLONE ACETATE

Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. Read about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEPO-MEDRONE Suspension for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB04	Methylprednisolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 161571, 185729, 28183, 28184, 28188, 28189, 32323, 32331, 374124, 374126, 375956, 375958, 381281
Country: IE	Health Products Regulatory Authority	Identifier(s): 20273, 20281, 20362
Country: MT	Medicines Authority	Identifier(s): MA505/02001, MA505/02003